Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CardioPhase® hsCRP

K-Number: K212559 · 2022-12-16

Decision Date2022-12-16
Product CodeNQD
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

CardioPhase® hsCRP is a medical device manufactured by Siemens Healthcare Diagnostics Products GmbH. It received FDA 510(k) clearance on 2022-12-16 under approval number K212559. The device is classified under product code NQD. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CardioPhase® hsCRP?

CardioPhase® hsCRP is a medical device that received FDA 510(k) clearance on 2022-12-16. It is manufactured by Siemens Healthcare Diagnostics Products GmbH. The 510(k) number is K212559.

When was CardioPhase® hsCRP approved by the FDA?

CardioPhase® hsCRP received FDA 510(k) clearance on 2022-12-16, under approval number K212559.

What company makes CardioPhase® hsCRP?

CardioPhase® hsCRP is manufactured by Siemens Healthcare Diagnostics Products GmbH.

What is the FDA product code for CardioPhase® hsCRP?

The FDA product code for CardioPhase® hsCRP is NQD.

Other Devices by Siemens Healthcare Diagnostics Products GmbH

View all 19 devices →

Related Devices (Code: NQD)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.